Outcomes for Standardized Home and Hospital‐Based Infusions of Infliximab for Children With Inflammatory Bowel Disease

Background: Pediatric inflammatory bowel disease (IBD) is commonly treated with infliximab in a hospital setting. Utilization of home infusions (HI) is increasing due to insurance mandates, travel time savings, and convenience. We evaluated adverse outcomes (AOs) of infliximab infusions in children...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of pediatric gastroenterology and nutrition 2023-06, Vol.76 (6), p.776-781
Hauptverfasser:	Gupta, Shivani R., Bricker, Josh, Boyle, Brendan M., Maltz, Ross M., Michel, Hilary K., Dotson, Jennifer L.
Format:	Artikel
Sprache:	eng
Schlagworte:	adverse outcomes Child Female Gastrointestinal Agents home infusions Hospitals Humans IBD Inflammatory Bowel Diseases - drug therapy Infliximab Infusions, Intravenous Male pediatrics Retrospective Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!